AP2001002249A0 - Process for making N-ARYL-ANTHRANILIC acids and their derivatives. - Google Patents
Process for making N-ARYL-ANTHRANILIC acids and their derivatives.Info
- Publication number
- AP2001002249A0 AP2001002249A0 APAP/P/2001/002249A AP2001002249A AP2001002249A0 AP 2001002249 A0 AP2001002249 A0 AP 2001002249A0 AP 2001002249 A AP2001002249 A AP 2001002249A AP 2001002249 A0 AP2001002249 A0 AP 2001002249A0
- Authority
- AP
- ARIPO
- Prior art keywords
- aryl
- derivatives
- making
- anthranilic acids
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/10—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/04—Formation of amino groups in compounds containing carboxyl groups
- C07C227/06—Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid
- C07C227/08—Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid by reaction of ammonia or amines with acids containing functional groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/08—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C221/00—Preparation of compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C253/00—Preparation of carboxylic acid nitriles
- C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Abstract
The present invention relates to a process for the preparation of N-arylanthranilic acids, and a process for the preparation of N-aryl anthranilic esters, amides, and hydroxamic esters.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22820600P | 2000-08-25 | 2000-08-25 | |
PCT/US2001/022948 WO2002018319A1 (en) | 2000-08-25 | 2001-07-20 | Process for making n-aryl-anthranilic acids and their derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
AP2001002249A0 true AP2001002249A0 (en) | 2001-09-30 |
Family
ID=22856235
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
APAP/P/2001/002249A AP2001002249A0 (en) | 2000-08-25 | 2001-07-20 | Process for making N-ARYL-ANTHRANILIC acids and their derivatives. |
Country Status (31)
Country | Link |
---|---|
EP (1) | EP1313694A1 (en) |
JP (1) | JP2004507518A (en) |
KR (1) | KR20030059115A (en) |
CN (1) | CN1458921A (en) |
AP (1) | AP2001002249A0 (en) |
AR (1) | AR032175A1 (en) |
AU (1) | AU2001277044A1 (en) |
BG (1) | BG107635A (en) |
BR (1) | BR0113520A (en) |
CA (1) | CA2420003A1 (en) |
CZ (1) | CZ2003477A3 (en) |
DO (1) | DOP2001000238A (en) |
EA (1) | EA200300187A1 (en) |
GT (1) | GT200100174A (en) |
HN (1) | HN2001000216A (en) |
HU (1) | HUP0300828A2 (en) |
IL (1) | IL154507A0 (en) |
IS (1) | IS6724A (en) |
MA (1) | MA26949A1 (en) |
MX (1) | MXPA03001654A (en) |
NO (1) | NO20030844L (en) |
PA (1) | PA8526501A1 (en) |
PE (1) | PE20020393A1 (en) |
PL (1) | PL360699A1 (en) |
SK (1) | SK2072003A3 (en) |
SV (1) | SV2002000601A (en) |
TN (1) | TNSN01127A1 (en) |
UY (1) | UY26908A1 (en) |
WO (1) | WO2002018319A1 (en) |
YU (1) | YU14303A (en) |
ZA (1) | ZA200301182B (en) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7235537B2 (en) | 2002-03-13 | 2007-06-26 | Array Biopharma, Inc. | N3 alkylated benzimidazole derivatives as MEK inhibitors |
EP2130536B1 (en) | 2002-03-13 | 2013-05-08 | Array Biopharma, Inc. | N3 alkylated benzimidazole derivatives as mek inhibitors |
US7538120B2 (en) | 2003-09-03 | 2009-05-26 | Array Biopharma Inc. | Method of treating inflammatory diseases |
US7144907B2 (en) | 2003-09-03 | 2006-12-05 | Array Biopharma Inc. | Heterocyclic inhibitors of MEK and methods of use thereof |
AU2004283148A1 (en) | 2003-10-21 | 2005-05-06 | Warner-Lambert Company Llc | Polymorphic form of N-[(R)-2,3-Dihydroxy-propoxy]-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide |
US7732616B2 (en) | 2003-11-19 | 2010-06-08 | Array Biopharma Inc. | Dihydropyridine and dihydropyridazine derivatives as inhibitors of MEK and methods of use thereof |
BRPI0416692A (en) | 2003-11-19 | 2007-01-30 | Array Biopharma Inc | heterocyclic mek inhibitors and methods of using these |
US7517994B2 (en) | 2003-11-19 | 2009-04-14 | Array Biopharma Inc. | Heterocyclic inhibitors of MEK and methods of use thereof |
EP1684694A2 (en) | 2003-11-21 | 2006-08-02 | Array Biopharma, Inc. | Akt protein kinase inhibitors |
UA89035C2 (en) * | 2003-12-03 | 2009-12-25 | Лео Фарма А/С | Hydroxamic acid esters and pharmaceutical use thereof |
AU2006235735C1 (en) | 2005-04-13 | 2013-10-31 | Astex Therapeutics Limited | Hydroxybenzamide derivatives and their use as inhibitors of Hsp90 |
BRPI0610139A2 (en) | 2005-05-18 | 2010-06-01 | Array Biopharma Inc | heterocyclic mek inhibitors and methods of using them |
US7754725B2 (en) | 2006-03-01 | 2010-07-13 | Astex Therapeutics Ltd. | Dihydroxyphenyl isoindolymethanones |
US8003651B2 (en) | 2006-07-06 | 2011-08-23 | Array Biopharma Inc. | Pyrimidyl cyclopentanes as AKT protein kinase inhibitors |
US8063050B2 (en) | 2006-07-06 | 2011-11-22 | Array Biopharma Inc. | Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors |
ATE532789T1 (en) | 2006-07-06 | 2011-11-15 | Array Biopharma Inc | DIHYDROTHIENOPYRIMIDINES AS ACT PROTEIN KINASE INHIBITORS |
EP2049546B1 (en) | 2006-07-06 | 2010-12-29 | Array Biopharma, Inc. | Dihydrofuro pyrimidines as akt protein kinase inhibitors |
JP5721949B2 (en) | 2006-10-12 | 2015-05-20 | アステックス、セラピューティックス、リミテッドAstex Therapeutics Limited | Compound drug |
WO2008044041A1 (en) | 2006-10-12 | 2008-04-17 | Astex Therapeutics Limited | Pharmaceutical combinations |
JP5518478B2 (en) | 2006-10-12 | 2014-06-11 | アステックス、セラピューティックス、リミテッド | Pharmaceutical compounds |
GB0620259D0 (en) | 2006-10-12 | 2006-11-22 | Astex Therapeutics Ltd | Pharmaceutical compounds |
US8779132B2 (en) | 2006-10-12 | 2014-07-15 | Astex Therapeutics Limited | Pharmaceutical compounds |
EP2073807A1 (en) | 2006-10-12 | 2009-07-01 | Astex Therapeutics Limited | Pharmaceutical combinations |
US9409886B2 (en) | 2007-07-05 | 2016-08-09 | Array Biopharma Inc. | Pyrimidyl cyclopentanes as AKT protein kinase inhibitors |
CA2692502C (en) | 2007-07-05 | 2016-03-01 | Array Biopharma Inc. | Pyrimidyl cyclopentanes as akt protein kinase inhibitors |
WO2009006569A1 (en) | 2007-07-05 | 2009-01-08 | Array Biopharma Inc. | Pyrimidyl cyclopentanes as akt protein kinase inhibitors |
US8846683B2 (en) | 2007-07-05 | 2014-09-30 | Array Biopharma, Inc. | Pyrimidyl cyclopentanes as Akt protein kinase inhibitors |
EP2247578B1 (en) | 2008-01-09 | 2013-05-22 | Array Biopharma, Inc. | Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors |
NZ586720A (en) | 2008-01-09 | 2012-11-30 | Array Biopharma Inc | Hydroxylated pyrimidyl cyclopentane as akt protein kinase inhibitor |
GB0806527D0 (en) | 2008-04-11 | 2008-05-14 | Astex Therapeutics Ltd | Pharmaceutical compounds |
CN101985428B (en) * | 2009-07-29 | 2014-02-12 | 杭州民生药业有限公司 | O-anilino benzoic acid derivatives or pharmaceutically acceptable salts thereof as well as preparation method and application thereof |
EP2536682A1 (en) * | 2010-02-19 | 2012-12-26 | Centre National De La Recherche Scientifique | Method for preparing chemical compounds of interest by nucleophilic aromatic substitution of aromatic carboxylic acid derivatives supporting at least one electro-attractive group |
CA2789361A1 (en) * | 2010-02-19 | 2011-08-25 | Jacques Mortier | Method for preparing chemical compounds of interest by aromatic nucleophilic substitution |
AU2012236166A1 (en) | 2011-04-01 | 2013-11-14 | Genentech, Inc. | Combinations of AKT inhibitor compounds and chemotherapeutic agents, and methods of use |
ES2688809T3 (en) | 2011-04-01 | 2018-11-07 | Genentech, Inc. | Combinations of AKT and MEK inhibitor compounds to treat cancer |
AU2013328929B2 (en) * | 2012-10-12 | 2018-01-04 | Exelixis, Inc. | Novel process for making compounds for use in the treatment of cancer |
CN112745237B (en) * | 2019-10-29 | 2023-06-20 | 中国科学院上海药物研究所 | 2-arylamine compound and preparation method and application thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3138636A (en) * | 1960-06-23 | 1964-06-23 | Parke Davis & Co | Anthranilic acid derivatives |
US6251943B1 (en) * | 1997-02-28 | 2001-06-26 | Warner-Lambert Company | Method of treating or preventing septic shock by administering a MEK inhibitor |
EP0993437B1 (en) * | 1997-07-01 | 2006-11-08 | Warner-Lambert Company Llc | 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as mek inhibitors |
DE69826662T2 (en) * | 1997-07-01 | 2005-02-17 | Warner-Lambert Co. Llc | 4-BROM OR 4-IOD-PHENYLAMINO-BENZHYDROXAMIC ACID DERIVATIVES AND THEIR USE AS MEK INHIBITORS |
CA2348236A1 (en) * | 1999-01-13 | 2000-07-20 | Stephen Douglas Barrett | 4-arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective mek inhibitors |
ATE286015T1 (en) * | 1999-04-21 | 2005-01-15 | Warner Lambert Co | METHOD FOR PRODUCING 2-(N-PHENYLALMINO)BENZOIC ACID |
-
2001
- 2001-07-20 PL PL36069901A patent/PL360699A1/en unknown
- 2001-07-20 IL IL15450701A patent/IL154507A0/en unknown
- 2001-07-20 SK SK207-2003A patent/SK2072003A3/en unknown
- 2001-07-20 CN CN01815869A patent/CN1458921A/en active Pending
- 2001-07-20 CZ CZ2003477A patent/CZ2003477A3/en unknown
- 2001-07-20 CA CA002420003A patent/CA2420003A1/en not_active Abandoned
- 2001-07-20 WO PCT/US2001/022948 patent/WO2002018319A1/en not_active Application Discontinuation
- 2001-07-20 EP EP01954824A patent/EP1313694A1/en not_active Withdrawn
- 2001-07-20 MX MXPA03001654A patent/MXPA03001654A/en unknown
- 2001-07-20 BR BR0113520-1A patent/BR0113520A/en not_active Application Discontinuation
- 2001-07-20 AP APAP/P/2001/002249A patent/AP2001002249A0/en unknown
- 2001-07-20 HU HU0300828A patent/HUP0300828A2/en unknown
- 2001-07-20 KR KR10-2003-7002675A patent/KR20030059115A/en not_active Application Discontinuation
- 2001-07-20 EA EA200300187A patent/EA200300187A1/en unknown
- 2001-07-20 YU YU14303A patent/YU14303A/en unknown
- 2001-07-20 JP JP2002523437A patent/JP2004507518A/en active Pending
- 2001-07-20 AU AU2001277044A patent/AU2001277044A1/en not_active Abandoned
- 2001-08-15 SV SV2001000601A patent/SV2002000601A/en not_active Application Discontinuation
- 2001-08-22 TN TNTNSN01127A patent/TNSN01127A1/en unknown
- 2001-08-23 PA PA20018526501A patent/PA8526501A1/en unknown
- 2001-08-24 PE PE2001000853A patent/PE20020393A1/en not_active Application Discontinuation
- 2001-08-24 AR ARP010104047A patent/AR032175A1/en unknown
- 2001-08-24 GT GT200100174A patent/GT200100174A/en unknown
- 2001-08-24 UY UY26908A patent/UY26908A1/en not_active Application Discontinuation
- 2001-08-24 DO DO2001000238A patent/DOP2001000238A/en unknown
- 2001-09-26 HN HN2001000216A patent/HN2001000216A/en unknown
-
2003
- 2003-02-12 ZA ZA200301182A patent/ZA200301182B/en unknown
- 2003-02-20 IS IS6724A patent/IS6724A/en unknown
- 2003-02-24 NO NO20030844A patent/NO20030844L/en not_active Application Discontinuation
- 2003-03-13 BG BG107635A patent/BG107635A/en unknown
- 2003-03-14 MA MA27069A patent/MA26949A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2001277044A1 (en) | 2002-03-13 |
NO20030844D0 (en) | 2003-02-24 |
MA26949A1 (en) | 2004-12-20 |
IS6724A (en) | 2003-02-20 |
AR032175A1 (en) | 2003-10-29 |
JP2004507518A (en) | 2004-03-11 |
MXPA03001654A (en) | 2004-09-10 |
PA8526501A1 (en) | 2002-07-30 |
KR20030059115A (en) | 2003-07-07 |
CA2420003A1 (en) | 2002-03-07 |
BR0113520A (en) | 2003-06-24 |
HN2001000216A (en) | 2002-05-22 |
IL154507A0 (en) | 2003-09-17 |
PE20020393A1 (en) | 2002-05-09 |
YU14303A (en) | 2006-08-17 |
CZ2003477A3 (en) | 2003-10-15 |
SV2002000601A (en) | 2002-04-03 |
BG107635A (en) | 2004-09-30 |
SK2072003A3 (en) | 2004-01-08 |
PL360699A1 (en) | 2004-09-20 |
UY26908A1 (en) | 2001-11-30 |
WO2002018319A1 (en) | 2002-03-07 |
GT200100174A (en) | 2002-07-18 |
TNSN01127A1 (en) | 2005-11-10 |
ZA200301182B (en) | 2004-05-12 |
HUP0300828A2 (en) | 2003-09-29 |
NO20030844L (en) | 2003-02-25 |
EP1313694A1 (en) | 2003-05-28 |
CN1458921A (en) | 2003-11-26 |
DOP2001000238A (en) | 2003-01-31 |
EA200300187A1 (en) | 2003-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TNSN01127A1 (en) | Process for making n-aryl-anthranilic acids and their derivatives | |
PL350453A1 (en) | N−cyanomethyl amides as protease inhibitors | |
BR0013885A (en) | Perfected tablets | |
HUP0004123A2 (en) | Carboxylic acid amide derivatives, process for their preparation and pharmaceutical compositions containing them | |
TNSN01108A1 (en) | Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids | |
HU0101336D0 (en) | Process for the preparation of perindopril and their pharmaceutically acceptable salts | |
IL154470A0 (en) | Use of derivatives of valproic acid amides and 2-valproenic acid amides for the treatment or prevention of pain and/or headache disorders | |
PL326322A1 (en) | Ciral methylphenyloxyazolydinones | |
MX9705726A (en) | Alkoximino acetic acid amides. | |
UA35607C2 (en) | oxazolidinonecarboxylic ACID derivatives, a process for the preparation thereof, pharmaceutical composition and a method for the preparation thereof | |
BG104243A (en) | Method for the synthesis of quinoline derivatives | |
MXPA03008837A (en) | A stable pharmaceutical composition of pravastatin. | |
PL346015A1 (en) | Methoximinophenylacetic acid amides | |
MXPA03002047A (en) | Substituted phenylcyclohexane carboxylic acid amides and the use thereof. | |
AU2002234066A1 (en) | Process for the production of amides | |
IL146257A0 (en) | Method of producing methoxyimido acetic amide | |
AU2002240828A1 (en) | Process for the preparation of alpha-aminosubstituted carboxylic acid amides | |
DE50010009D1 (en) | Hydroxamsäurederivate | |
JO2258B1 (en) | Process for preparation of hydroxamic acids | |
HUP9903371A3 (en) | Carboxylic acid derivatives, their production and use of them for producing pharmaceutical compositions |